Department of Pancreatic Surgery, St James's University Hospital, Leeds, UK.
HPB (Oxford). 2014 Jun;16(6):582-91. doi: 10.1111/j.1477-2574.2012.00614.x. Epub 2012 Nov 19.
Data have indicated that the lymph node ratio (LNR) may be a better prognostic indicator than lymph node status in pancreatic cancer.
To analyse the value of the LNR in patients undergoing resection for periampullary carcinomas.
A cut off value of 0.2 was assigned to the LNR in accordance with published studies. The impact of histopathological factors including a LNR was analysed using Kaplan-Meier and Cox regression methods.
In total, 551 patients undergoing a resection (January 2000 to December 2010) were analysed. The median lymph node yield was 15, and 198 (34%) patients had a LNR > 0.2. In patients with a LNR of > 0.2, the median overall survival (OS) was 18 versus 33 months in patients with an LNR < 0.2 (P < 0.001). Univariate analysis demonstrated a LNR > 0.2, T and N stage, vascular or perineural invasion, grade and resection margin status to be significantly associated with OS. On multivariate analysis, only a LNR > 0.2, vascular or perineural invasion and margin positivity remained significant. In N1 disease, a LNR was able to distinguish survival in patients with a similar lymph node burden, and correlated with more aggressive tumour pathological variables.
A LNR > 0.2, and not lymph note status, is an independent prognostic factor for OS indicating the LNR should be utilized in outcome stratification.
数据表明,淋巴结比率(LNR)可能是比胰腺癌淋巴结状态更好的预后指标。
分析 LNR 在接受胰头十二指肠切除术的患者中的价值。
根据已发表的研究,将 LNR 的截断值设定为 0.2。使用 Kaplan-Meier 和 Cox 回归方法分析包括 LNR 在内的组织病理学因素的影响。
共分析了 551 例接受手术(2000 年 1 月至 2010 年 12 月)的患者。淋巴结收获中位数为 15 个,198 例(34%)患者的 LNR > 0.2。在 LNR > 0.2 的患者中,中位总生存期(OS)为 18 个月,而 LNR < 0.2 的患者为 33 个月(P < 0.001)。单因素分析显示,LNR > 0.2、T 和 N 分期、血管或神经周围侵犯、分级和切缘状态与 OS 显著相关。多因素分析显示,只有 LNR > 0.2、血管或神经周围侵犯和切缘阳性仍然具有显著意义。在 N1 疾病中,LNR 能够区分具有相似淋巴结负担的患者的生存情况,并且与更具侵袭性的肿瘤病理变量相关。
LNR > 0.2 是 OS 的独立预后因素,而不是淋巴结状态,表明 LNR 应用于预后分层。